Samarendra Mohanty
Company: Nanoscope Therapeutics Inc
Job title: Chief Scientific Officer & President
Seminars:
Panel Discussion: Overcoming the Limitations of Dry AMD not having a Recognised Disease Model 11:00 am
Incorporating more NHPs in preclinical testing to better inform the safety profile of dry AMD therapeutics Understanding why developing a relevant animal model for Dry AMD remains a pertinent challengeRead more
day: Conference Day 1